相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study
Simon D. Roger et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Catherine M. Clase et al.
KIDNEY INTERNATIONAL (2020)
Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE)
W. Frank Peacock et al.
ACADEMIC EMERGENCY MEDICINE (2020)
ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials
Yaru Zhang et al.
DRUGS (2020)
Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study
Naoki Kashihara et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
Min Jun et al.
PLOS ONE (2019)
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia A 12-Month Phase 3 Study
Bruce S. Spinowitz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure
Gianluigi Savarese et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2019)
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia
Steven Fishbane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age
J. Ariana Noel et al.
JAMA INTERNAL MEDICINE (2019)
Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
Taylor V. Hunt et al.
CLINICAL KIDNEY JOURNAL (2019)
Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
Naoki Kashihara et al.
KIDNEY INTERNATIONAL REPORTS (2019)
Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE
Simon D. Roger et al.
AMERICAN JOURNAL OF NEPHROLOGY (2019)
Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia
Bairbre A. McNicholas et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia
Calvin J. Meaney et al.
PHARMACOTHERAPY (2017)
Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project
Ghassan Bandak et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Diagnosis and treatment of hyperkalemia
Biff F. Palmer et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2017)
Advances in the management of hyperkalemia in chronic kidney disease
Andrea C. J. Cowan et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy
Jared A. Schaefer et al.
ANNALS OF PHARMACOTHERAPY (2016)
Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study
Amanda E. Hagan et al.
CLINICAL NEPHROLOGY (2016)
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
Laurence Lepage et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
Stephen R. Ash et al.
KIDNEY INTERNATIONAL (2015)
Sodium Zirconium Cyclosilicate for Urgent Therapy of Severe Hyperkalemia
Mikhail Kosiborod et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sodium Zirconium Cyclosilicate in Hyperkalemia
David K. Packham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Hyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes
Jagadish Khanagavi et al.
ARCHIVES OF MEDICAL SCIENCE (2014)
Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies
Guang Hao et al.
BMC CARDIOVASCULAR DISORDERS (2014)
Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia The HARMONIZE Randomized Clinical Trial
Mikhail Kosiborod et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Characterization of Structure and Function of ZS-9, α K+ Selective Ion Trap
Fiona Stavros et al.
PLOS ONE (2014)
Prediction and Management of Hyperkalemia Across the Spectrum of Chronic Kidney Disease
Lvana Lazich et al.
SEMINARS IN NEPHROLOGY (2014)
分享论文
